Medtronic Receives FDA Approval for New Cardiac Systems with Distance Wireless Telemetry

 

Medtronic Receives FDA Approval for New Cardiac Systems with Distance Wireless Telemetry Concerto CRT-D and Virtuoso ICD transmit patient data remotely and automatically to physicians, enabling better care MINNEAPOLIS May 17, 2006 Medtronic, Inc., (NYSE: MDT) today announced United States Food and Drug Administration approval of the Medtronic Concerto"/Virtuoso" line of implantable cardiac devices, Medtronics next generation of cardiac rhythm disease management products. The approval coincides with Heart Rhythm 2006, the Heart Rhythm Societys 27th Annual Scientific Sessions the pre-eminent gathering of medical professionals from across the globe who specialize in the hearts rhythms and electrical function. Market availability of these devices will follow in June 2006.

Medtronic Receives FDA Approval for New Cardiac Systems with Distance Wireless Telemetry

Hat Tip:  Medgadget